Tuesday, December 10th, 2024: Day One - ET (Eastern Time, GMT-05:00)
- Allie Spica - Senior Conference Producer, Informa Connect
- Joseph Cappello - Head, Channel Accounts, Incyte Corporation
Join us for an insightful keynote address that examines the critical developments of 2024 and offers a strategic outlook for 2025.
- Gain a comprehensive understanding of the current reimbursement landscape, highlighting key changes, challenges and opportunities
- Explore how the evolving site-of-care trends are shaping patient access and channel dynamics
- Analyze the influence of cost of goods on channel strategies and profitability, with a focus on emerging trends and best practices
- Bill Roth - Senior Vice President of Consulting, Blue Fin Group, An IntegriChain Company
As market mergers, joint ventures and more transform the life sciences marketplace, hear from industry experts on what is changing and what is being forecasted as areas of interest moving forward.
- How are the products moving and who are the major players, looking specifically at payers, retailers and distributors
- What are the major drivers for disruption in the marketplace
- Shawn Pelc - Healthcare Middle Market Banking, Citibank
- Joyce Lau - Vice President, Bain Capital
- Examine how legacy distribution channels are evolving to incorporate technological advancements and what innovative approaches new channels are introducing
- Discuss strategies for seamlessly integrating technology to enhance the patient journey, from prescription to delivery and beyond
- Understand how manufacturers are redefining their approach to data and technology to drive efficiency, improve patient outcomes and optimize distribution processes
- Tom Doyle - Senior Vice President of Sales, Chief Customer Officer for BioPharma Services, Cencora
- Tim Cernohous - Senior Vice President & President, Community Retail and LTC Pharmacy, Cencora
- Karen Martell - Vice President, Partnerships, Alto Pharmacy
Drug manufacturers are closing the gaps in patient access, affordability and adherence by utilizing commercialization models that personalize patient care, improve healthcare accessibility, and drive market momentum. In this presentation, industry experts will explore how direct-to-patient models shorten the time to diagnosis and therapy to improve patient outcomes.
- Kevin O'Meara - Vice President, Patient Services, EVERSANA
As we quickly approach 2025 with redesign coming into effect, understand how organizations have been actively preparing for the impacts, strategically positioning themselves, and responding to the regulatory and payer developments, including specific the prospects for implementation of Medicare “fair price”. This session will also discuss impacts on the distribution of products, such as the use of dual WACs and WAC reductions in direct to consumer offers.
- William Sarraille - Regulatory Consultant, Sarraille & Associates
- Gain insights on transforming commercial organizations and driving revenue growth
- Learn strategies for managing costs effectively in specialty models
- Understand how to spearhead cross-functional partnerships for strategic planning and brand development
- John Harlow - Chief Commercial Officer, Melinta Therapeutics
This session is designed for attendees who are new to their role, new to the industry or new to their company and looking for a primer course on the foundational knowledge needed for success.
- Understand of trade and channel management for market access and product distribution
- Delve into the governing regulatory landscape, including the Drug Supply Chain Security Act (DSCSA) and other relevant regulations
- Learn about building and maintaining effective partnerships with channel stakeholders, including wholesalers, pharmacies and distributors
- Understand the basics of market access, including pricing, reimbursement and formulary placement strategies
- Explore how digital technologies are transforming trade and channel management in the pharmaceutical industry, including e-commerce and digital marketing strategies
In this advanced session, connect with fellow trade, channel and distribution experts, to share experiences and benchmark on common challenges. Take part in this critical, interactive knowledge-exchange in an open, collaborative format.
**This summit is an exclusive, senior-level benchmarking discussion. Attendees should have a minimum of 7 years experience in trade and channel strategies and must currently be employed at life science manufacturer. Informa Connect reserves the right to qualify participants for this Summit. during this time. Please email Alexandra.spica@informa.com to reserve your seat.
This workshop provides a comprehensive overview of health systems, their structure and their interactions in the wider healthcare landscape.
- Gain Insights into key components of health systems including:
- Payer dynamics
- Formulary management
- Reimbursement practices
- Understand the economics around health systems and integrated delivery networks
- Deep dive into market access and contract negotiations
- Identify key challenges facing health systems today and their implications for pharmaceutical companies
- Explore opportunities for collaboration between pharmaceutical companies and health systems to improve patient outcomes and reduce healthcare costs
- John Robicsek - Assistant Vice President - Strategy, Business, and Program Development, Atrium Health